Publications & Works

Publication Network
Articles 37
All (37)
SCI-E, SSCI, AHCI (27)
SCI-E, SSCI, AHCI, ESCI (30)
ESCI (3)
Scopus (31)
TRDizin (6)
Other Publications (3)

1. Identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches

Oruçoğlu B., Çetin İ., Şimşek H., Topçul M. R., Çalışkan M., Aydın C., et al.
SCIENTIFIC REPORTS , vol.15, no.1, 2025 (SCI-Expanded) identifier identifier identifier

2. Study of Photochemical and Photophysical Properties of Indium(III) and Titanium(IV) Phthalocyanine Derivatives Containing 3,5-Di-tert-Butyl Groups

Zeki K., ÇETİN İ., TOPÇUL M. R., SALİH B., Khene S., CANLICA M.
RUSSIAN JOURNAL OF INORGANIC CHEMISTRY , 2025 (SCI-Expanded) identifier

3. Combined use of WNT signal pathway inhibitor FH535 and docetaxel causes mitotic catastrophism and antiproliferative effect in non-small cell lung cancer.

Avşar E. N., Çetin İ.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.71, no.2, pp.61-66, 2025 (SCI-Expanded) Sustainable Development identifier

4. Alpha-mangostin and nab-paclitaxel in breast cancer cell models: improved antitumor efficacy through combination therapy.

Özgen Ö., Çetin İ., Atalar F., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.71, no.1, pp.52-59, 2025 (SCI-Expanded) identifier identifier

5. Evaluation of the antiproliferative effect of histone deacetylase inhibitor (HDACi) CI-994 and Liposomal Cisplatin LipoPlatin on MCF-7 and MDA-MB-231 cells as monotherapy and combined therapy.

Çetin İ., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.70, no.12, pp.81-87, 2025 (SCI-Expanded) identifier

6. Comparison of the effects of crizotinib as monotherapy and as combination therapy with butyric acid on different breast cancer cells

TOPÇUL M. R., ÇETİN İ., Pulat E., ÇALIŞKAN M.
ONCOLOGY LETTERS , vol.29, no.1, 2025 (SCI-Expanded) Sustainable Development identifier identifier identifier

7. Antiproliferative effects of hazelnut cell culture extract on the different cancer cell lines.

Ari S., Cetin I., Dogan A., Topcul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.70, no.11, pp.89-94, 2024 (SCI-Expanded) Sustainable Development identifier identifier

8. Pediatric Acute Myeloid Leukemia and Target Therapies

Kıroğlu H. B., Çetin İ., Topçul M. R.
International Journal of Pediatric Acute Myeloid Leukemia and Target Therapies , vol.46, no.4, pp.1-6, 2024 (Peer-Reviewed Journal)

9. Effects of targeting highly expressed in cancer protein 1 (Hec1) inhibitor INH 1 in breast cancer cell lines In Vitro

Topcul M., ÇETİN İ.
CELLULAR AND MOLECULAR BIOLOGY , vol.69, no.14, pp.109-113, 2023 (SCI-Expanded) Sustainable Development identifier identifier identifier

10. An Overview of the Effect of the Wnt Signaling Pathway in Lung Cancer.

Avşar E. N., Çetin İ., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.68, no.8, pp.41-46, 2022 (SCI-Expanded) Sustainable Development identifier

11. Antiproliferative Effects of EGFR inhibitor Cetuximab and PARP Inhibitor Combination on Non-Small Cell Lung Cancer Cell Line A549 and Cervical Cancer Cell Line HeLa.

Çetin İ., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.68, no.8, pp.47-51, 2022 (SCI-Expanded) Sustainable Development identifier

12. Investigation of the Effects of the Endogenous Cannabinoid Anandamide on Luminal A Breast Cancer Cell Line MCF-7.

Çetin İ., Topçul M. R.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.68, no.4, pp.129-133, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier

13. Antitumor Activity of Tubulin-Binding Agent MPC-6827 on Different Types of Cancer Cell Lines.

Topçul M. R., Çetin İ.
Cellular and molecular biology (Noisy-le-Grand, France) , vol.68, no.4, pp.108-112, 2022 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier

14. Anticancer Activities of a Metal-Free Phthalocyanine on MCF-7 and MDAMB-231 Cells and Singlet Oxygen Production as a Photosensitizer in PDT

CANLICA M., ÇETİN İ.
Journal of the Turkish Chemical Society, Section A: Chemistry , vol.8, no.4, pp.1025-1034, 2021 (Scopus)

15. Hec1/Nek2 Mitotic Pathway Inhibitor INH1 Inhibits the Cell Kinetic Parameters of A549 and HeLa Cells

ÇETİN İ.
BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY , vol.64, 2021 (SCI-Expanded) Sustainable Development identifier identifier

16. Bioproduction, structure elucidation and in vitro antiproliferative effect of eumelanin pigment fromStreptomyces parvusBSB49

Bayram S., Dengiz C., Gerçek Y. C., Cetin I., Topcul M.
ARCHIVES OF MICROBIOLOGY , vol.202, no.9, pp.2401-2409, 2020 (SCI-Expanded) identifier identifier identifier

17. In vitro antiproliferative effect of four ball-type phthalocyanines linked by t-butylcatechol and high singlet oxygen production

CANLICA M., TOPÇUL M. R., ÇETİN İ.
JOURNAL OF COORDINATION CHEMISTRY , vol.73, no.23, pp.3291-3305, 2020 (SCI-Expanded) Sustainable Development identifier identifier

18. Can mesenchymal stem cells be used to treat COVID-19-induced pneumonia (Review)

ÇETİN İ., TOPÇUL M. R.
Biomedical Reports , vol.13, pp.1-6, 2020 (Scopus) identifier identifier

19. Antiproliferative effects of cetuximab on triple negative breast cancer cell line MDA-MB-231

ÇETİN İ.
CUMHURIYET SCIENCE JOURNAL , vol.41, no.3, pp.706-711, 2020 (Peer-Reviewed Journal) Sustainable Development identifier

20. Evaluation of the cytotoxic effect of Ly2109761 on HeLa cells using the xCELLigence RTCA system

Cetin I., Topcul M. R.
ONCOLOGY LETTERS , vol.17, pp.683-687, 2019 (SCI-Expanded) identifier identifier identifier

21. Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives

Cetin I., Elma P. E., Topcull M. R., Karali N. L.
ISTANBUL JOURNAL OF PHARMACY , vol.48, pp.63-67, 2018 (ESCI) identifier

22. In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells

Topcul M. R., Cetin I., Turan S. O., Ozar M. O. K.
ONCOLOGY REPORTS , vol.40, pp.527-535, 2018 (SCI-Expanded) Sustainable Development identifier identifier identifier

23. Effects of Navelbine on Cell Proliferation of Hela Cell Culture

Çetin İ., Kolusayın Ozar M. Ö., Topçul M. R.
European International Journal of Science and Technology , vol.7, no.5, pp.18-28, 2018 (Peer-Reviewed Journal)

24. In vitro antiproliferative effects of nab-paclitaxel with liposomal cisplatin on MDA-MB-231 and MCF-7 breast cancer cell lines

Cetin I., Topcul M. R.
JOURNAL OF BUON , vol.22, no.2, pp.347-354, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

25. Investigation of Cytotoxic Effects of Some Novel Synthesized Iminothiazolidinone Derivatives on HeLa Cell Line (CCL2)

Tuğcu F., TOPÇUL M. R., ÇETİN İ., ÜNLÜ Y. S., GERÇEK Y. C., MORGİL H., et al.
IUFS JOURNAL OF BİOLOGY , vol.1, no.75, pp.15-33, 2016 (Peer-Reviewed Journal) Sustainable Development

26. In vitro cytotoxic effect of tyrosine kinase inhibitor sunitinib malate alone and in combination with hyperthermia on breast adenocarcinoma MCF-7 cells

Topcul M. R., Cetin I.
JOURNAL OF BUON , vol.21, no.3, pp.556-563, 2016 (SCI-Expanded) identifier identifier identifier

27. Clinical significance of epithelial-mesenchymal transition and cancer stem cells

Topcul M. R., Cetin I.
JOURNAL OF BUON , vol.21, no.2, pp.312-319, 2016 (SCI-Expanded) Sustainable Development identifier identifier identifier

28. Effects of metformin on cell kinetic parameters of MCF-7 breast cancer cells in vitro

Topcul M. R., ÇETİN İ.
Asian Pacific Journal of Cancer Prevention , vol.16, no.6, pp.2351-2354, 2015 (SCI-Expanded) Sustainable Development identifier identifier

29. Effects of Hypobaric Conditions on Apoptosis Signalling Pathways in HeLa Cells

Arican G. O., Khalilia W., Serbes U., Akman G., Cetin İ., Arican E.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.12, pp.5043-5047, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

30. Endpoint of Cancer Treatment: Targeted Therapies

Topcul M. R., Cetin I.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, pp.4395-4403, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

31. Triple Negative Breast Cancer

Cetin I., Topcul M.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.6, pp.2427-2431, 2014 (SCI-Expanded) Sustainable Development identifier identifier identifier

32. An Innovative Therapeutic Approch in Oncology: Hyperthermia

TOPÇUL M. R., ÇETİN İ.
European International Journal of Science and Technology , vol.2, pp.73-80, 2013 (Peer-Reviewed Journal)

33. The effects of anastrozole on the proliferation of FM3A cells

Topcul M. R., Cetin I., Ozar M. O. K.
JOURNAL OF BUON , vol.18, no.4, pp.874-878, 2013 (SCI-Expanded) identifier identifier identifier

34. Nanotechnology in the field of clinical oncology Klinik onkoloji alanında nanoteknoloji

TOPÇUL M. R., ÇETİN İ.
Marmara Medical Journal , vol.26, no.1, 2013 (ESCI) identifier identifier

35. Effects of Femara and Tamoxifen on Proliferation of FM3A Cells in Culture

Topcul M. R., Topçul F., Cetin İ.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, pp.2819-2822, 2013 (SCI-Expanded) identifier identifier identifier

36. Synthesis and chemotherapeutic activities of 5-chloro-1H-indole-2,3-dione 3-thiosemicarbazones

Ermut G., KARALI N. L., ÇETİN İ., TOPÇUL M. R., Birteksoz S.
MARMARA PHARMACEUTICAL JOURNAL , vol.17, no.2, pp.147-154, 2013 (ESCI) identifier identifier

37. Cancer stem cells in oncology

Cetin I., Topcul M. R.
JOURNAL OF BUON , vol.17, no.4, pp.644-648, 2012 (SCI-Expanded) Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 12

1. Discovery of SARS-CoV-2 3CLpro Inhibitor by Drug Repurposing Approach Using Biosafe SARS-CoV-2 Replicon

Oruçoğlu B., Çetin İ., Topçul M. R., Gül Ş.
9th International BAU Drug Design Congress, İstanbul, Turkey, 29 November - 02 December 2023, vol.1, no.12, pp.45, (Summary Text)

2. St. Thomas, del Nido ve Custodial Kardiyopleji Sıvıları'nın in vitro insan Akciğer Hücre Kültüründeki Etkilerinin Gerçek Zamanlı Olarak Değerlendirilmesi

KARDUZ G., ÇETİN İ., TOPÇUL M. R., ULUGÖL H., AKSU U., TORAMAN F.
25. Ulusal Göğüs Kalp Damar Anestezi Yoğun Bakım Kongresi, İstanbul, Turkey, 20 - 22 April 2019, vol.1, no.1, pp.1-3, (Full Text) Creative Commons License

3. Nab-Paklitaksel ve Parp İnhibitörünün Birlikte Kullanımının Rahim Ağzı Kanser Hücreleri Üzerine In Vitro Etkilerinin Değerlendirilmesi

TOPÇUL M. R., ÇETİN İ.
Zeugma II. Uluslararası Multi Disipliner Çalışmalar Kongresi, Gaziantep, Turkey, 18 - 20 January 2019, vol.1, pp.11-15, (Full Text) Sustainable Development

4. In Vitro Antiproliferative Effects of Histone Deacetylases Inhibitor CI-994 on MCF-7 Breast Cancer Cell Line

ÇETİN İ.
II. ULUSLARARASI MULTİDİSİPLİNER AKADEMİK ÇALIŞMALAR SEMPOZYUMU, İstanbul, Turkey, 16 - 17 November 2018, vol.1, pp.291-299, (Full Text) Sustainable Development

5. In vitro Cytotoxic Effect of Metformin on Triple Negative Breast Cancer Cell Line MDA-MB-231

ÇETİN İ.
International Eurasian Conference on Biological and Chemical Sciences (EurasianBioChem 2018), Ankara, Turkey, 26 - 20 April 2018, pp.45-51, (Full Text) Sustainable Development

6. Antiproliferative Activity of Hypobaric Conditions and Evaluation of Bcl-2 Gene Expression on HeLa Cells

ÖZCAN F. G., Khalilia W., Serbes U., AKMAN G., ÇETİN İ., ARICAN E.
VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 - 25 May 2017, pp.198, (Full Text)

7. COMPARISON OF THE EFFECTS OF ALBUMIN BOUND PACLITAXEL (Abi-007) ON TRIPLE NEGATIVE BREAST CANCER CELL LINE MDA-MB-231 AND LUMINAL A BREAST CANCER CELL LINE MCF-7

ÇETİN İ., TOPÇUL M. R.
VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 - 25 May 2017, vol.2, no.1, pp.70, (Summary Text) Sustainable Development

8. In Vitro Antiproliferative Effects of LY2109761 on Hela Cell Culture

TOPÇUL M. R., ÇETİN İ.
VI: International Congress of Molecular Medicine, İstanbul, Turkey, 22 May 2017 - 25 May 2018, vol.2, no.1, pp.114, (Full Text)

9. Evaluation cytotoxic and genotoxic effects of some novel synthesized iminothializodinon derivatives on hela cell line (CCL2)

Tuğcu T., ÇETİN İ., TOPÇUL M. R., Ünlü Y. S., GERÇEK Y. C., ÖZ G.
4th International Meeting on Pharmacy & Pharmaceutical Sciences, İstanbul, Turkey, 18 - 21 September 2014, pp.178, (Full Text)

10. Antiproliferative and Apoptotic Answer of Amifostine against Gamma Radiation on HeLa Cell Culture

ÖZCAN ARICAN F. G., Dağdeviren Ö., Serbes U., ÇETİN İ.
9 th NCRI Cancer Conference, Liverpool, United Kingdom, 1 - 04 November 2013, no.9, pp.137-138, (Full Text)

11. Synthesis and biological Evoluation of 1H-indole-2,3-dione 3-(N-(4-sulfamoylphenyl)thiosemicarbazone)derivate as anticancer an antiviral agents.

Karalı N., Kızılırmak M., ÇETİN İ., TOPÇUL M. R.
14th Tetrahedron Symposium, Viyana, Austria, 1 - 04 June 2013, pp.79, (Full Text)

12. Düşük Basınç (Hipobarik) Koşullarının Doku Kültüründe Anti-Proliferatif Ve Apoptotik Etkilerinin Moleküler Mekanizmalarının Araştırılması

ÖZCAN ARICAN F. G., Khalilia W., Serbes U., AKMAN G., ÇETİN İ., ARICAN E.
21. Ulusal Biyoloji Kongresi, İzmir, Turkey, 3 - 07 September 2012, pp.1333, (Full Text)
Books 7

1. Effects of Amifostine Against Gamma-radiation on HeLa Cells and Apoptotic Genes Expression

ÖZCAN F. G., UGUR S., ÇETİN İ., DAĞDEVİREN ÖZSÖYLEMEZ Ö.
in: From Molecular Symphony to Therapeutic Harmonies: Exploring Nutrigenomics, Enzymatic Frontiers, Flavonoid Therapeutics, and Autoimmune Skin Challenges, Metin ERTAŞ, Editor, BIDGE, İstanbul, pp.122-137, 2023

2. Stem Cells in Cell Therapy and Regenerative Medicine

TOPÇUL M. R., ÇETİN İ.
Omics International, Heathrow, 2018

3. Treatment of Colon Cancer

TOPÇUL M. R., ÇETİN İ.
in: Clinical Diagnosis and Therapy of Colorectal Cancer, Schneider R., Editor, Omics Electric Ebook Publishing, Foster City, pp.1-15, 2015 Sustainable Development

4. Latest Advances in Cancer Stem Cell Research; Treatment Options for Colorectal Cancer

ÇETİN İ., TOPÇUL M. R.
in: Modern Technology Present and Future, Macha M.A., Editor, Omıcs Group Ebooks, Foster City, Usa., pp.1-13, 2015

5. Breast Cancer

TOPÇUL M. R., ÇETİN İ.
in: Cancer: Disease of the age, El-Sharkawy A M, Editor, Omıcs Group Ebooks, Foster City, pp.1-20, 2015 Sustainable Development

6. Mutation Prevention

TOPÇUL M. R., ÇETİN İ.
in: Cancer Treatment Strategies, Ahmed M. Malki, Editor, Omıcs Group Ebooks, Foster City, pp.1-13, 2015 Sustainable Development

7. The Biology of Cancer Metastasis

TOPÇUL M. R., ÇETİN İ.
in: Cancer: Disease of the age, Ahmed M El-Sharkawy, Editor, Omıcs Group Ebooks, Foster City, pp.1-20, 2015 Sustainable Development
Other Publications 1

1. TÜBİTAK 2017 BİLİM OLİMPİYATLARI BİYOLOJİ SORULARI

Topçul M. R., Çetin İ.
Other, pp.1-25, 2017
Metrics

Publication

57

Publication (WoS)

30

Publication (Scopus)

31

Citation (WoS)

168

H-Index (WoS)

7

Citation (Scopus)

214

H-Index (Scopus)

8

Citation (Scholar)

189

H-Index (Scholar)

7

Citation (Sum Other)

2

Project

21

Intellectual Property

1

Thesis Advisory

2

Open Access

4
UN Sustainable Development Goals